The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Triumvira Immunologics, Inc
A phase I/II trial investigating safety and efficacy of autologous TAC01-HER2 in relapsed or refractory solid tumors.
 
Benjamin L. Schlechter
Honoraria - Quercegen Pharmaceuticals
 
Ecaterina Elena Dumbrava
Consulting or Advisory Role - Bolt Biotherapeutics; Mersana; Orum Therapeutics; Summit Therapeutics
Speakers' Bureau - PMV Pharma
Research Funding - Aileron Therapeutics; Amgen; Aprea Therapeutics; Astex Pharmaceuticals; Bayer; Bellicum Pharmaceuticals; Boehringer Ingelheim; Bolt Biotherapeutics; Compugen; Dragonfly Therapeutics; Genentech; Gilead Sciences; Immunocore; Mereo BioPharma 5; Mersana; PMV Pharma; Poseida Therapeutics; Rain Oncology; Sanofi; Seagen; Sotio; TRACON Pharma; Triumvira Immunologics, Inc; Unum Therapeutics
Travel, Accommodations, Expenses - ASCO/Pfizer Grant; Banner MD Anderson Cancer Center; Li-Fraumeni Syndrome Association; Rain Oncology; Triumvira Immunologics, Inc
 
Mridula Annette George
Consulting or Advisory Role - OBI Pharma; Seagen
Research Funding - Incyte; Oncolytics
Travel, Accommodations, Expenses - OBI Pharma; OBI Pharma
Other Relationship - Oncology Learning Network
 
Samuel Saibil
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Immunocore; Janssen; Novartis; Sanofi
Travel, Accommodations, Expenses - Iovance Biotherapeutics
 
Marcus O. Butler
Honoraria - Bristol-Myers Squibb; Merck; Novartis; Roche
Consulting or Advisory Role - Adaptimmune; Adaptimmune; Bristol-Myers Squibb; EMD Serono; Genzyme; GlaxoSmithKline; GlaxoSmithKline; IDEAYA Biosciences; Immunocore; Immunovaccine; Instil Bio; Iovance Biotherapeutics; LaRoche Posay; Medison; Merck; Novartis; Pfizer; Regeneron; Sanofi; Sun Pharma
Research Funding - Merck (Inst); Novartis Canada Pharmaceuticals Inc (Inst); Takara Bio (Inst)
Expert Testimony - Merck
 
Antonio Giordano
Consulting or Advisory Role - Pfizer
 
Rishi Surana
Honoraria - Grupo Oncoclinicas
Travel, Accommodations, Expenses - DAVA Oncology
 
Chih-Yi Liao
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Exelixis; Genentech; Histosonics; Incyte; Ipsen; Lexicon; Lilly; QED Therapeutics; TransThera Biosciences
Speakers' Bureau - AstraZeneca; Eisai; Exelixis; Incyte
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - AstraZeneca; Eisai; Exelixis; Incyte; Ipsen
 
Jordan Weiss
No Relationships to Disclose
 
Brooke Pieke
No Relationships to Disclose
 
Miriam Gavriliuc
No Relationships to Disclose
 
Emily Lichtenstein
No Relationships to Disclose
 
Maria Apostolopoulou
Employment - Triumvira Immunologics, Inc
Patents, Royalties, Other Intellectual Property - Wang X, Apostolopoulou M, Wetherby K (filed 03/21/2019) Apparatus and method for collecting multi-tiered particles from a biological sample. U.S. Provisional Pat. Ser. No. 62/821,598
 
Courtney Burke
No Relationships to Disclose
 
Bushra Qureshi
No Relationships to Disclose
 
Deyaa R Adib
Employment - Triumvira Immunologics, Inc
Leadership - Triumvira Immunologics, Inc
Stock and Other Ownership Interests - Triumvira Immunologics, Inc
Consulting or Advisory Role - Eagle Pharmaceuticals; Epizyme; Ikena Oncology; Mythic Therapeutics; OBI Pharma; RAIN
Research Funding - Eagle Pharmaceuticals; Epizyme; Ikena Oncology; Mythic Therapeutics; OBI Pharma; RAIN
Travel, Accommodations, Expenses - Eagle Pharmaceuticals; Epizyme; Ikena Oncology; Mythic Therapeutics; OBI Pharma; RAIN
 
Daniel Olson
Consulting or Advisory Role - Gerson Lehrman Group; Iovance Biotherapeutics; MJH Life Sciences; Novartis; Novartis